Overstimulation risks include menstrual irregularity, cyst formation, or estrogen dominance
[3] Current evidence does not support using these medications specifically for anxiety management outside their licensed indications
Oh M, Alkhushaym N, Fallatah S, Althagafi A, Aljadeed R, Alsowaida Y, et al
Recent headlines, like the Wall Street Journals coverage, highlight surging interest in new medications, along with growing concerns from the FDA regarding the use of compounded and unapproved versions of GLP-1-based treatments
GLP-1 compounding with telehealth front door became the darling of quite a few VCs and startups since 2022